Radius Health (RDUS) Tops Q4 EPS by 19c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Radius Health, Inc.: Fourth Quarter and Full Year Results
February 25, 2021 7:00 AM ESTFull year 2020 TYMLOS® U.S. net sales of $208 million was year-over-year growth of 20%Q4 2020 TYMLOS U.S. net sales: $60 million was 8% growth vs. Q4 2019 and 19% growth vs. Q3 2020New patient starts: increased by 26% in Q4 2020 vs. Q3 2020ATOM, wearABLe and EMERALD studies: on schedule for 2H 2021 read-outsJapan regulatory process: remains on trackRAD011 asset integration and forward progress... More
